MARKET

ALT

ALT

Altimmune
NASDAQ
4.380
-0.110
-2.45%
After Hours: 4.381 +0.001 +0.02% 19:58 02/20 EST
OPEN
4.490
PREV CLOSE
4.490
HIGH
4.510
LOW
4.360
VOLUME
4.14M
TURNOVER
--
52 WEEK HIGH
7.73
52 WEEK LOW
2.900
MARKET CAP
548.51M
P/E (TTM)
-4.0977
1D
5D
1M
3M
1Y
5Y
1D
Altimmune management to meet with Piper Sandler
TipRanks · 1d ago
Weekly Report: what happened at ALT last week (0209-0213)?
Weekly Report · 5d ago
Altimmune initiated with a Buy at Titan Partners
TipRanks · 02/13 14:55
Short Report: VNET Group short interest at 4-month high
TipRanks · 02/09 11:20
Weekly Report: what happened at ALT last week (0202-0206)?
Weekly Report · 02/09 09:04
Altimmune Sets 2026 Annual Stockholder Meeting Timeline
TipRanks · 02/03 21:40
Altimmune Outlook: Where Pemvidutide Phase 3 Is Heading In 2026
Seeking Alpha · 02/03 20:46
BUZZ-US-listed Novo shares slip after company flags sharp 2026 sales drop
Reuters · 02/03 17:48
More
About ALT
Altimmune, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing next-generation peptide-based therapeutics. It is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity, metabolic dysfunction-associated steatohepatitis (MASH) and other indications. Activation of the GLP-1 and glucagon receptors is believed to mimic the complementary effects of diet and exercise on weight loss, with GLP-1 suppressing appetite and glucagon increasing energy expenditure. Glucagon is also recognized as having direct effects on hepatic fat metabolism, to rapid reductions in levels of liver fat and serum lipids. The Company has completed the MOMENTUM Phase II obesity trial and is being studied in the IMPACT Phase IIb MASH trial. The Company also develops and commercializes surfactant-functionalized (EuPort domain) incretin-based peptide therapeutics, including (GLP-1-glucagon)/oxyntomodulin, and variants.

Webull offers Altimmune Inc stock information, including NASDAQ: ALT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALT stock methods without spending real money on the virtual paper trading platform.